Open Now
Contact Information
600 Abbott Drive , Broomall, Pennsylvania 19008, United States
Detailed Information
Mirmont Outpatient Center Broomall/Main Line Health
-
Services:
- No formal relationship with prescribing entity
- In-network prescribing entity
- Treatment for other addiction disorder
- Substance use disorder counseling
- Anger management
- Relapse prevention
- 12-step facilitation
- Brief intervention
- Cognitive behavioral therapy
- Telemedicine/telehealth therapy
- Motivational interviewing
- Trauma-related counseling
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Assistance with obtaining social services
- Outreach to persons in the community
- Screening for tobacco use
- Comprehensive substance use assessment
- Screening for substance use
- Screening for mental disorders
- Comprehensive mental health assessment
- Private health insurance
- Medicare
- Federal, or any government funding for substance use treatment programs
- Cash or self-payment
- Medicaid
- Relapse prevention with naltrexone
- Prescribes buprenorphine
- Accepts clients using MAT but prescribed elsewhere
- Prescribes naltrexone
- Buprenorphine maintenance
- Individual counseling
- Smoking/vaping/tobacco cessation counseling
- HIV or AIDS education, counseling, or support
- Substance use disorder education
- Hepatitis education, counseling, or support
- Group counseling
- Family counseling
- Health education services other than HIV/AIDS or hepatitis
- Smoking permitted in designated area
- Suicide prevention services
- Mental health services
- Transportation assistance
- Social skills development
- Adolescents
- Young adults
- State Substance use treatment agency
- The Joint Commission
- State mental health department
- Disulfiram
- Acamprosate (CampralĀ®)
- Buprenorphine without naloxone
- Buprenorphine with naloxone
- Buprenorphine (extended-release, injectable)
- Naltrexone (oral)
- Non-nicotine smoking/tobacco cessation
- Medication for mental disorders
- Naltrexone (extended-release, injectable)
- Outpatient day treatment or partial hospitalization
- Regular outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient
- Intensive outpatient treatment
- No formal relationship with prescribing entity
- In-network prescribing entity
- Female
- Male
- Vaping permitted in designated area
- Private non-profit organization
- Drug or alcohol urine screening
- Breathalyzer or blood alcohol testing
- Drug and alcohol oral fluid testing
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Children/Adolescents
- Naloxone and overdose education
- Discharge Planning
- Aftercare/continuing care
- Outcome follow-up after discharge
External Opioid Medications Source
Other Services
Treatment Approaches
Type of Alcohol Use Disorder Treatment
Opioid Medications used in Treatment
Recovery Support Services
Assessment/Pre-treatment
Payment/Insurance/Funding Accepted
Type of Opioid Treatment
Education and Counseling Services
Facility Smoking Policy
Ancillary Services
Special Programs/Groups Offered
License/Certification/Accreditation
Pharmacotherapies
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
External Source of Medications Used for Alcohol Use Disorder Treatment
Gender Accepted
Facility Vaping Policy
Facility Operation (e.g., Private, Public)
Testing
Type of Care
Age Groups Accepted
Transitional Services
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm